ACTION, in conjunction with Berlin Heart, Inc., launched the first prospective FDA regulated device trial using a pediatric ventricular assist device (VAD) registry in November 2022. Enrollment in the trial has been completed as of August 11, 2023, just 10 months after launch.
ACTION is proud to release our newest education material for patients and caregivers for the HVAD™ System.
Join us a day before the VAD summit for our ACTION Fall 2023 Meeting. We will be focusing on our role in clinical trials for the larger meeting, with shorter meeting to follow for the Berlin Heart Active Driver Trial PIs.
Check out the newest One Page Summary (OPS) featuring the Berlin Heart EXCOR® Active This OPS includes an overview of the device pump settings, system preferences, pump optimization, power sources, accessories, alarms …
The Heart Center at St. Louis Children’s Hospital and Washington University School of Medicine, invite you to the return of the International Pediatric VAD and Heart Failure Summit.
Check out the Berlin Heart One Page Summary (OPS). This OPS includes pump settings and function, cannulation strategies, blood pump and system components, power sources, as well as highlighting anticoagulation, …
Join us for a virtual clinician-focused education event featuring “in real life”(IRL) Berlin Heart EXCOR® patient care.
The ACTION registry is being used to conduct prospective trials. Currently the Berlin Active Driver is being studied at 20 ACTION sites.
One weekend, Jimmie noticed his 16-month-old daughter, Brynn, was breathing strangely. One week later, Brynn was heading into surgery to be placed on a VAD. For half a year, Jimmie and his wife, Kristyn, waited by the phone for the transplant call. The family had many long nights, learned how to navigate their lives with a VAD, and finally reached the end of a dark tunnel.
Read the second part of our “A Family of Big Hearts,” featuring Lindsey.
